ArticleFrontiers in public health2026
German nationwide inpatient data on the post-COVID-19 syndrome: an update.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Healthcare utilization patterns and medication burden in post-COVID syndrome: a cross-sectional analysis reveals four phenotypes.Frontiers in health services · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-COVID syndrome (PCS) continues to pose a serious public health issue, with persistent symptoms requiring ongoing medical care after the acute phase of infection. Despite its clinical significance, data on its burden on hospital systems and healthcare costs have been limited. This study updates the national analysis of PCS-related hospitalizations in Germany for the year 2023, focusing on patient demographics, primary diagnoses, procedures, and inpatient costs. Methods: Using nationwide data from the Institute for the Hospital Remuneration System (InEK) and the German Diagnosis-Related Groups (G-DRG), the study identified patients with PCS via the diagnosis code "U09.9!" as a secondary diagnosis. Parameters included age, sex, diagnoses, procedures, length of stay (LOS), and direct cost estimates. Incidence rates were calculated using official population data. Results: There were 17,209 PCS-related hospital admissions, translating to 48.9 cases per 100,000 people. Women represented 60% of cases, with peak prevalence in the 55-60 age group. Common diagnoses were chronic fatigue, dyspnea, and general malaise; procedures mainly involved respiratory and neurological evaluations. Only 4% required care dependency assessments. The average LOS was 8.3 days (SD 11.6 days). LOS showed a right-skewed distribution. The median LOS was 7.1 days [interquartile range (IQR): 3.9-7.9 days]. Total inpatient costs reached €67.9 million. Compared to early-pandemic data, the number of PCS-related hospitalizations decreased substantially in 2023, while diagnostic complexity and inpatient resource utilization remained high. Conclusion: PCS continues to challenge healthcare systems, underlining the need for ongoing research, policy adjustments, and resource planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.